This is a working overview of IGF-1, written for readers who want more than a one-paragraph summary but less than a textbook.
This page was last updated on 2026-04-10 and is reviewed periodically as new material appears.
Tesamorelin is a synthetic peptide that belongs to the growth hormone-releasing hormone (GHRH) family. Its sequence corresponds to the fully active 44-amino-acid form of human GHRH, with a single structural modification: the addition of a trans-3-hexenoyl group at the N-terminus. That modification is not found in the naturally occurring hormone and was introduced deliberately during development to improve stability against enzymatic degradation. The compound is therefore best described as a stabilized analogue rather than a naturally occurring peptide.
The native hormone is produced in the hypothalamus and acts on the anterior pituitary. Binding of GHRH to its receptor stimulates synthesis and release of growth hormone into circulation. Because the analogue retains the receptor-binding region of the parent sequence, it engages the same receptor and triggers the same downstream signaling. The result is increased growth hormone secretion from pituitary cells, which in turn influences hepatic production of insulin-like growth factor 1. This axis is the basis for the compound's measured biological effects.
Tesamorelin binds to growth hormone-releasing hormone receptors on somatotroph cells in the anterior pituitary. Receptor activation increases intracellular cyclic AMP and promotes synthesis and secretion of growth hormone. Because the peptide mimics endogenous GHRH, it amplifies the normal pulsatile release of growth hormone rather than providing exogenous growth hormone directly. This upstream action distinguishes tesamorelin from recombinant growth hormone preparations and from growth hormone secretagogues that act at different receptors.
Stimulated growth hormone release leads to hepatic production of insulin-like growth factor 1, a key mediator of many growth hormone effects. In clinical studies, tesamorelin increased IGF-1 levels in a dose-dependent manner, although the response varies among individuals. The drug's effect on visceral fat is thought to involve growth hormone-mediated lipolysis and altered adipocyte metabolism. Muscle mass and lean body mass have also been assessed as secondary outcomes, but changes are generally smaller and less consistent than fat reductions.
| Property | Value | Notes |
|---|---|---|
| Molecular formula | C221H366N72O67S | Reflects a 44-residue peptide with one N-terminal modification |
| Approximate molecular weight | 5136 Da | Sequence length and single acyl group determine the mass |
| Appearance | White to off-white lyophilized powder | Typical form of a purified synthetic peptide |
| Solubility class | Soluble in water and aqueous buffer | Peptide backbone favors aqueous dissolution |
| Common synonyms | GHRH(1-44) analogue; Egrifta | Descriptive name and approved brand name |
Tesamorelin is a synthetic peptide of 44 amino acids that reproduces the sequence of human growth hormone-releasing hormone (GHRH) and carries a trans-3-hexenoyl group on its N-terminal tyrosine. That small fatty-acid modification blocks cleavage by dipeptidyl peptidase-4, the enzyme that rapidly degrades native GHRH in plasma. The result is a molecule with a longer circulating half-life than the natural hormone while retaining the same receptor target. It is supplied as a lyophilized powder for reconstitution and belongs to the broader class of GHRH analogs studied for effects on pituitary growth hormone secretion.
Development work on the compound, originally designated TH9507, focused on conditions in which reduced growth hormone signaling is thought to contribute to altered body composition. The United States Food and Drug Administration approved it in 2010 for the treatment of excess visceral abdominal fat in adults with human immunodeficiency virus infection and lipodystrophy. Later research examined other populations, including adults with mild cognitive impairment, where a large trial did not meet its primary endpoints. This mixed record illustrates how a single mechanism can produce clear effects in one setting and inconclusive results in another.
Lyophilized material is typically held under refrigeration between two and eight degrees Celsius, shielded from light and ambient moisture. Peptides of this size adsorb to glass and plastic, so working procedures often call for low-binding containers and as few transfers as possible. Absorbed water during weighing shifts the apparent mass of a sample, and controlling room humidity reduces that source of error. Once dissolved, solutions are kept cold and used within the interval printed on the accompanying label or certificate. Degradation accelerates markedly in dilute aqueous form.
Identity and purity are judged through a combination of chromatographic and mass spectrometric techniques. Reversed-phase high-performance liquid chromatography separates the intact peptide from truncated, oxidized, and deamidated variants, and the resulting peak-area percentages yield a purity figure. Electrospray ionization mass spectrometry confirms the expected molecular mass and can expose unanticipated modifications. Amino acid analysis and peptide mapping support sequence fidelity, while water content, pH, sterility, and bacterial endotoxin testing describe the physical and microbiological attributes of a finished lot.
== Posthumous recognition == In 1959 she became the first woman elected to the Poultry Historical Society Hall of Fame. She was inducted into the National Women's Hall of Fame in 2002, the American Society of Heating, Refrigerating and Air-Conditioning Engineers Hall of Fame in 2007, and the National Inventors Hall of Fame in 2018.
Half of them were placed in the center of this grain-producing area, another half scattered among 48 compounds along the course of the river. In total, the qullqas of the Mantaro Valley had a storage area of 170,000 square meters, possibly the largest storage facilities in the Inca Empire and in pre-Columbian America. Illustrating the quantity of stored items, these qullqas supplied and equipped an army of 35,000 soldiers during the Spanish conquest of the 1530s. Cochabamba in present day Bolivia, at a relatively low elevation of 2,500 metres (8,200 ft) was developed as a state farm by the Incas for maize production. On the hills to the south of the growing area above Lake Cotapachi were 2,400 qullqas, each cone shaped, about 3 metres (9.8 ft) in height and diameter and clustered in parallel lines in an area of 61 hectares (150 acres). Some of the maize produced in Cochabamba was transported by Llama caravan to the regional center of Paria, 100 kilometres (62 mi) west of Cochabamba, and hence on to Cuzco. One thousand qullqas have been discovered at Paria. The Campo de Pucara in Argentina, 18 kilometres (11 mi) southwest of the city of Salta, had 1,717 qullqas of about the same size and apparently the same function as the qullqas at Cochabamba. All other provincial centers of the Empire had large numbers of qullqas built row after row on nearby hills.
2024 Bushey killings: Police announce that a manhunt is underway for Kyle Clifford, a 26-year-old man suspected of murdering three women in Bushey, Hertfordshire, using a crossbow. The public is warned not to approach him. Police identify the three women as 61-year-old Carol Hunt, wife of BBC Racing commentator John Hunt, and two of their daughters, Hannah Hunt, 28 and Louise Hunt, 25. Clifford is found and arrested in Enfield by the early evening. Euro 2024: England win 2–1 against the Netherlands, with Ollie Watkins scoring a 90th minute winning goal, taking them through to the final against Spain. 11 July Data shows the UK economy grew by 0.4% in May, expanding more than had been expected. A manhunt is launched after two suitcases containing human remains are found at the Clifton Suspension Bridge in Bristol. 12 July Four migrants die and 63 are rescued after their small boat capsizes in an attempt to cross the English Channel. According to International Organization for Migration this brings the total deaths resulting from such crossing attempts to more than 20 so far for 2024. Royal Mail unveil their new logo, based on the Tudor Crown used in the royal cypher of King Charles III, which replaces the St Edward's Crown used by Queen Elizabeth II. The first post box with the new logo is in Cambourne, Cambridgeshire. Following his guilty verdict on 4 July, Gavin Plumb is sentenced to life imprisonment, with a minimum term of 15 years.
Sources: en.wikipedia.org
== Portfolio == Bigfoot's portfolio also includes the Bigfoot Autonomy Diabetes Management Program with a closed-loop, automated insulin delivery system, sometimes referred to as an “artificial pancreas.” It received the FDA Breakthrough Device designation.
== Mechanism of generator function == When loaded with the parent isotope germanium-68, these generators function similarly to technetium-99m generators, in both cases using a process similar to ion chromatography. The stationary phase is either metal-free or alumina, TiO2 or SnO2, onto which germanium-68 is adsorbed. The use of metal-free columns allows direct labeling of 68Ga without prepurification, hence making production of gallium-68-radiolabeled compounds more convenient. The mobile phase is a solvent able to elute (wash out) gallium-68 (III) (68Ga3+) after it has been produced by electron capture decay from the immobilized (absorbed) germanium-68. Currently, such 68Ga (III) is easily eluted with a few mL of 0.05 M, 0.1 M or 1.0 M hydrochloric acid from generators using metal-free tin dioxide or titanium dioxide adsorbents, respectively, within 1 to 2 minutes. With generators of tin dioxide and titanium dioxide-based adsorbents, there once remained more than an hour of pharmaceutical preparation to attach the gallium-68 (III) as a tracer to the pharmaceutical molecules DOTATOC or DOTA-TATE, so that the total preparation time for the resulting radiopharmaceutical is typically longer than the 68Ga isotope half-life. This fact required that these radiopharmaceuticals be made on-site in most cases, and the on-site generator is required to minimize the time losses.
=== Pharmacokinetics === The bioavailability of levodopa is 30%. It is metabolized into dopamine by aromatic-l-amino-acid decarboxylase (AAAD) in the central nervous system and periphery. The elimination half-life of levodopa is 0.75 to 1.5 hours. It is excreted 70–80% in urine.
Sources: en.wikipedia.org
It shares the 44-residue sequence of human GHRH but carries an added trans-3-hexenoyl group at its N-terminus. That addition does not occur in the natural hormone and serves mainly to resist enzymatic breakdown. The receptor target and signaling pathway remain the same.
It binds the growth hormone-releasing hormone receptor on anterior pituitary cells. Activation of that receptor promotes synthesis and release of growth hormone. The effect propagates through the growth hormone and insulin-like growth factor 1 axis.
Native GHRH is cleared quickly by peptidases, which limits how long it can stimulate its receptor. The added group hinders one of the primary cleavage enzymes. The practical consequence is a longer period of receptor activity per dose.
It targets the growth hormone-releasing hormone receptor on pituitary somatotroph cells. Binding stimulates cyclic AMP signaling and growth hormone secretion. This is the same receptor used by endogenous GHRH.